Crossmark

Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65

Crossref DOI link: https://doi.org/10.1038/s41434-018-0031-x

Published Online: 2018-07-25

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Georgiadis, A.

Duran, Y.

Ribeiro, J.

Abelleira-Hervas, L.

Robbie, S. J.

Sünkel-Laing, B.

Fourali, S.

Gonzalez-Cordero, A.

Cristante, E.

Michaelides, M.

Bainbridge, J. W. B.

Smith, A. J.

Ali, R. R.
License Information

Text and Data Mining valid from 2018-07-25
More Information

Article History

First Online: 25 July 2018